Differentiated Thyroid Gland Carcinoma
Also known as: Differentiated Thyroid Carcinoma (DTC) / Differentiated Thyroid Carcinoma / Differentiated thyroid carcinoma (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Terminated | 1 |
| DB14509 | Lithium carbonate | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB14765 | Rivoceranib | 2 | Unknown Status | 1 |
| DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
| DB05153 | Cabozantinib | Not Available | Completed | 1 |
| DB08875 | Cabozantinib | Not Available | Completed | 1 |
| DB09078 | Lenvatinib | Not Available | Completed | 1 |